Neuro,
I understand your frustration. But I hope that you will continue to post. You are the reason that I feel ok with Cortex - disappointed yes - and reasonably positive about its future (easy from $0.49 I suppose :-> ).

In any event, I sincerely appreciate your thoughtful, informative and balanced posts.

Jim,
Based on your posts, I fear you will be disappointed in the CC. Nonetheless, i look forward to it, and think it will be a positive for the pps.

GFP927z wrote in part: "Either way, I think Dr. Tracy's analysis will turn out to be correct" The "good" GFP927z is back! Welcome back!

Wow. Quite a question there Younger Brother!

Dr. Tracy/others - Some basic questions for a "baseline":

1. What specifically is the issue with CX-717?
2. How likely is it that the dosage restriction will be lifted or significantly increased?
3. Will Organon ever disclose any results? Estimates of when? If positive, what are the ramifications to Cortex?
4. Once a high impact deal is done, what is a reasonable development timeline for a motivated big pharma licensee?
5. Why does a big pharma simply not buy this company?

Sincere thanks for answers!